Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell Lymphoma
Background. Diffuse large B-cell lymphoma (DLBCL) is one of the largest lymphoma subcategories. Usually, 50%–70% of DLBCL patients can be cured by the standard treatment. But, at least one third have bad prognosis. Based on this situation, the research on DLBCL therapy strategy is still indispensabl...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2024/4619644 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850173438462787584 |
|---|---|
| author | Shijun Wang Xiaoqin Wang Guixia Li Pengcheng Feng |
| author_facet | Shijun Wang Xiaoqin Wang Guixia Li Pengcheng Feng |
| author_sort | Shijun Wang |
| collection | DOAJ |
| description | Background. Diffuse large B-cell lymphoma (DLBCL) is one of the largest lymphoma subcategories. Usually, 50%–70% of DLBCL patients can be cured by the standard treatment. But, at least one third have bad prognosis. Based on this situation, the research on DLBCL therapy strategy is still indispensable. Methods. A prognostic signature was built according to the public data and bioinformatics methods, the stability and reliability was assessed and validated. GSEA was performed to explore the difference in different groups. Consensus clustering and immune infiltration analysis were conducted comprehensively. Results. In this work, a signature based on multiple metabolism-associated genes (MTGs) was established, containing 16 MTGs, to predict the prognosis of DLBCL patients. The accuracy and effectiveness of this signature have been verified by three external validation sets. According to the risk formula, DLBCL patients were divided into high- and low-risk groups, and the survival rate of the low-risk group was significantly higher than that of the high-risk group. Furthermore, gene set enrichment analysis (GSEA) demonstrated that beta-alanine metabolism and regulation of actin cytoskeleton signal pathways were enriched in the low-risk group. The actual survival and nomogram-predicted survival matched well both in the training cohort and verification cohorts. Conclusion. In general, our prognostic signature can provide reliable and valuable information for medical workers in predicting the prognosis of DLBCL. A preprint was made available by the research square in the following link: “https://www.researchsquare.com/article/rs-1468741/v2.” |
| format | Article |
| id | doaj-art-d31fb66ef0964c8cbacdbdb3e69cc4e9 |
| institution | OA Journals |
| issn | 2210-7185 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Analytical Cellular Pathology |
| spelling | doaj-art-d31fb66ef0964c8cbacdbdb3e69cc4e92025-08-20T02:19:51ZengWileyAnalytical Cellular Pathology2210-71852024-01-01202410.1155/2024/4619644Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell LymphomaShijun Wang0Xiaoqin Wang1Guixia Li2Pengcheng Feng3Department of ChemistryDepartment of AnesthesiologyDepartment of Basic MedicineDepartment of Basic MedicineBackground. Diffuse large B-cell lymphoma (DLBCL) is one of the largest lymphoma subcategories. Usually, 50%–70% of DLBCL patients can be cured by the standard treatment. But, at least one third have bad prognosis. Based on this situation, the research on DLBCL therapy strategy is still indispensable. Methods. A prognostic signature was built according to the public data and bioinformatics methods, the stability and reliability was assessed and validated. GSEA was performed to explore the difference in different groups. Consensus clustering and immune infiltration analysis were conducted comprehensively. Results. In this work, a signature based on multiple metabolism-associated genes (MTGs) was established, containing 16 MTGs, to predict the prognosis of DLBCL patients. The accuracy and effectiveness of this signature have been verified by three external validation sets. According to the risk formula, DLBCL patients were divided into high- and low-risk groups, and the survival rate of the low-risk group was significantly higher than that of the high-risk group. Furthermore, gene set enrichment analysis (GSEA) demonstrated that beta-alanine metabolism and regulation of actin cytoskeleton signal pathways were enriched in the low-risk group. The actual survival and nomogram-predicted survival matched well both in the training cohort and verification cohorts. Conclusion. In general, our prognostic signature can provide reliable and valuable information for medical workers in predicting the prognosis of DLBCL. A preprint was made available by the research square in the following link: “https://www.researchsquare.com/article/rs-1468741/v2.”http://dx.doi.org/10.1155/2024/4619644 |
| spellingShingle | Shijun Wang Xiaoqin Wang Guixia Li Pengcheng Feng Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell Lymphoma Analytical Cellular Pathology |
| title | Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell Lymphoma |
| title_full | Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell Lymphoma |
| title_fullStr | Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell Lymphoma |
| title_full_unstemmed | Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell Lymphoma |
| title_short | Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell Lymphoma |
| title_sort | identification of a 16 mtgs prognostic signature in diffuse large b cell lymphoma |
| url | http://dx.doi.org/10.1155/2024/4619644 |
| work_keys_str_mv | AT shijunwang identificationofa16mtgsprognosticsignatureindiffuselargebcelllymphoma AT xiaoqinwang identificationofa16mtgsprognosticsignatureindiffuselargebcelllymphoma AT guixiali identificationofa16mtgsprognosticsignatureindiffuselargebcelllymphoma AT pengchengfeng identificationofa16mtgsprognosticsignatureindiffuselargebcelllymphoma |